GOVX
Price
$0.90
Change
-$0.00 (-0.00%)
Updated
Jun 26, 01:20 PM (EDT)
Capitalization
14.28M
GRI
Price
$1.29
Change
-$0.06 (-4.44%)
Updated
Jun 26, 01:19 PM (EDT)
Capitalization
3.17M
Interact to see
Advertisement

GOVX vs GRI

Header iconGOVX vs GRI Comparison
Open Charts GOVX vs GRIBanner chart's image
GeoVax Labs
Price$0.90
Change-$0.00 (-0.00%)
Volume$2.6K
Capitalization14.28M
GRI Bio
Price$1.29
Change-$0.06 (-4.44%)
Volume$200
Capitalization3.17M
GOVX vs GRI Comparison Chart in %
Loading...
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOVX vs. GRI commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOVX is a Hold and GRI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GOVX: $0.90 vs. GRI: $1.35)
Brand notoriety: GOVX and GRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOVX: 83% vs. GRI: 10%
Market capitalization -- GOVX: $14.28M vs. GRI: $3.17M
GOVX [@Biotechnology] is valued at $14.28M. GRI’s [@Biotechnology] market capitalization is $3.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOVX’s FA Score shows that 1 FA rating(s) are green whileGRI’s FA Score has 2 green FA rating(s).

  • GOVX’s FA Score: 1 green, 4 red.
  • GRI’s FA Score: 2 green, 3 red.
According to our system of comparison, GRI is a better buy in the long-term than GOVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOVX’s TA Score shows that 5 TA indicator(s) are bullish while GRI’s TA Score has 2 bullish TA indicator(s).

  • GOVX’s TA Score: 5 bullish, 4 bearish.
  • GRI’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, GOVX is a better buy in the short-term than GRI.

Price Growth

GOVX (@Biotechnology) experienced а -3.02% price change this week, while GRI (@Biotechnology) price change was -3.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.78%. For the same industry, the average monthly price growth was +31.36%, and the average quarterly price growth was +15.04%.

Reported Earning Dates

GOVX is expected to report earnings on Mar 27, 2025.

GRI is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+1.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOVX($14.3M) has a higher market cap than GRI($3.17M). GOVX YTD gains are higher at: -63.692 vs. GRI (-90.414). GRI has higher annual earnings (EBITDA): -9.39M vs. GOVX (-24.4M). GOVX has more cash in the bank: 7.44M vs. GRI (3.28M). GRI has less debt than GOVX: GRI (108K) vs GOVX (142K). GOVX has higher revenues than GRI: GOVX (5.59M) vs GRI (0).
GOVXGRIGOVX / GRI
Capitalization14.3M3.17M451%
EBITDA-24.4M-9.39M260%
Gain YTD-63.692-90.41470%
P/E RatioN/A0.03-
Revenue5.59M0-
Total Cash7.44M3.28M227%
Total Debt142K108K131%
FUNDAMENTALS RATINGS
GOVX vs GRI: Fundamental Ratings
GOVX
GRI
OUTLOOK RATING
1..100
232
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
1
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9365
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GRI's Valuation (1) in the null industry is in the same range as GOVX (28). This means that GRI’s stock grew similarly to GOVX’s over the last 12 months.

GRI's Profit vs Risk Rating (100) in the null industry is in the same range as GOVX (100). This means that GRI’s stock grew similarly to GOVX’s over the last 12 months.

GRI's SMR Rating (100) in the null industry is in the same range as GOVX (100). This means that GRI’s stock grew similarly to GOVX’s over the last 12 months.

GRI's Price Growth Rating (65) in the null industry is in the same range as GOVX (93). This means that GRI’s stock grew similarly to GOVX’s over the last 12 months.

GRI's P/E Growth Rating (3) in the null industry is significantly better than the same rating for GOVX (100). This means that GRI’s stock grew significantly faster than GOVX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOVXGRI
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
86%
Bullish Trend 9 days ago
88%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GOVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRS1.630.11
+7.24%
Aclaris Therapeutics
BAH101.341.18
+1.18%
Booz Allen Hamilton Holding Corp
WLKP21.89-0.08
-0.36%
Westlake Chemical Partners LP
IOSP83.50-0.41
-0.49%
Innospec
UBX0.79-0.01
-1.45%
Unity Biotechnology

GOVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOVX has been loosely correlated with TOVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GOVX jumps, then TOVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOVX
1D Price
Change %
GOVX100%
-0.58%
TOVX - GOVX
54%
Loosely correlated
-1.80%
GRI - GOVX
37%
Loosely correlated
N/A
VRAX - GOVX
35%
Loosely correlated
-5.18%
CING - GOVX
34%
Loosely correlated
+0.74%
MAIA - GOVX
32%
Poorly correlated
-3.45%
More

GRI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRI has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if GRI jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRI
1D Price
Change %
GRI100%
N/A
IDYA - GRI
54%
Loosely correlated
+1.06%
SNSE - GRI
40%
Loosely correlated
+1.48%
NLSP - GRI
38%
Loosely correlated
+4.41%
GOVX - GRI
37%
Loosely correlated
-0.58%
INAB - GRI
36%
Loosely correlated
-2.68%
More